Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Geiss

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
MMW Fortschritte Der Medizin|May 4, 2006
[Diabetic dyslipoproteinemia]H C Geiss, K Parhofer
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|December 9, 2000
Efficacy of different low-density lipoprotein apheresis methodsK G Parhofer, H C Geiss, P Schwandt
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 2, 2003
Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemiaH C Geiss, M Dietlein, K G Parhofer
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 6, 2001
Parameters of childhood obesity and their relationship to cardiovascular risk factors in healthy prepubescent childrenH C Geiss, K G Parhofer, P Schwandt
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 12, 2002
Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemiaH C Geiss, P Schwandt, K G Parhofer
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 18, 2002
Global cardiovascular risk in children and their families: the Prevention Education Program (PEP), NürnbergP Schwandt, H C Geiss, G M Haas
Journal of Internal Medicine|March 30, 1999
Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresisH C Geiss, K G Parhofer, P Schwandt
Metabolism: Clinical and Experimental|July 28, 2001
Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjectsH C Geiss, C Otto, P Schwandt, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 24, 2001
The Prevention Education Program (PEP) Nuremberg: design and baseline data of a family oriented intervention studyE Ohrig, H C Geiss, G M Haas, et al.
Deutsche Medizinische Wochenschrift (1946)|May 3, 2002
[Effect of glucose control on lipid levels in patients with type 2 diabetes]K G Parhofer, E Laubach, H C Geiss, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
MMW Fortschritte Der Medizin|May 4, 2006
[Diabetic dyslipoproteinemia]H C Geiss, K Parhofer
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|December 9, 2000
Efficacy of different low-density lipoprotein apheresis methodsK G Parhofer, H C Geiss, P Schwandt
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 2, 2003
Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemiaH C Geiss, M Dietlein, K G Parhofer
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 6, 2001
Parameters of childhood obesity and their relationship to cardiovascular risk factors in healthy prepubescent childrenH C Geiss, K G Parhofer, P Schwandt
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 12, 2002
Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemiaH C Geiss, P Schwandt, K G Parhofer
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 18, 2002
Global cardiovascular risk in children and their families: the Prevention Education Program (PEP), NürnbergP Schwandt, H C Geiss, G M Haas
Journal of Internal Medicine|March 30, 1999
Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresisH C Geiss, K G Parhofer, P Schwandt
Metabolism: Clinical and Experimental|July 28, 2001
Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjectsH C Geiss, C Otto, P Schwandt, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 24, 2001
The Prevention Education Program (PEP) Nuremberg: design and baseline data of a family oriented intervention studyE Ohrig, H C Geiss, G M Haas, et al.
Deutsche Medizinische Wochenschrift (1946)|May 3, 2002
[Effect of glucose control on lipid levels in patients with type 2 diabetes]K G Parhofer, E Laubach, H C Geiss, et al.
Pageof 3